The global joint pain injections market size is projected to hit around USD 7.59 billion by 2030 from USD 4.43 billion in 2022 with a CAGR of 6.9% during the forecast period 2022 to 2030.
Join pain injections are used to treat swollen or painful joints. It is used to treat after an injury or if you have arthritis. It is injected directly into the painful joint. It is also sometimes used to treat muscle pain. It provides relief from pain and swelling and makes movement easier. Its benefits can last for several months. It is only available on prescription. A specially trained doctor gives it. It treats inflammatory joint conditions, such as rheumatoid arthritis, gout, psoriatic arthritis, tendinitis, bursitis, Carpal Tunnel Syndrome, and osteoarthritis.
Main people consider joint replacement surgery as the chronic joint pain treatment option. However, there are non-surgical options also available. These injections are formulated to reduce inflammation and pain. Pain relief is almost immediate once it is injected into the joint. It also works as a slow-release treatment that provides pain relief for several weeks. It has long-lasting effects. It is recommended for people suffering from chronic joint pain.
Growth Factors
Joint pain injections are injected into the joints. It works to reduce inflammation and discomfort. The global market is majorly driven by the increasing prevalence of inflammatory joint disorders such as psoriatic arthritis, rheumatoid arthritis, bursitis, osteoarthritis, and gout. In line with this, the symptoms of arthritis are joint pain, stiffness, redness, and a decrease in physical activity. Osteoarthritis and rheumatoid arthritis are inflammatory illness that affects the hands and feet. Osteoarthritis happens due to a loss of bone mineral density and a lack of physical activity. Corticosteroids and hyaluronic acid injections are used to relieve discomfort in afflicted joint locations. The rising prevalence of arthritis and musculoskeletal problems boosts the overall demand for joint pain injections. It is highly required by people aged 65 and over. They are more prone to joint discomfort. Factors such as the increasing geriatric population, rising cases of joint disorders, and growing unmet healthcare needs positively influence market growth across the globe. Elderly people are more prone to joint diseases.
Placental tissue matrix and platelet rich plasma injection are used to provide relief from discomfort and reduce inflammation. The new product releases, the increasing prevalence of arthritis, and the rising geriatric patient population catalyze market growth across the globe. Moreover, the heavy investments by governments across various countries in the production of novel and cost-effective medicines create a positive outlook for the market. All these factors propel the growth of the market over the forecast period. The increasing prevalence of osteoarthritis favors market growth. The rising need for cost-effective therapies drives the market growth. The growing senior population and technological advancements strengthen the market growth. The surging demand for minimally invasive operations drives the market growth.
Joint Pain Injections Market Report Scope:
| Report Coverage | Details |
| Market Size in 2022 | USD 4.43 Billion |
| Market Size In 2030 | USD 7.59 Billion |
| Growth Rate From 2022 to 2030 | CAGR of 6.9% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | By Injection Type and By Distribution Channel |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Report Highlights:
Based on the product, the global joint pain injections market is divided into corticosteroid injections, hyaluronic acid (HA) injections, platelet-rich plasma injections, and others. The hyaluronic acid injections dominated the market and accounted for the largest revenue share. This is due to the increasing number of patients with osteoarthritis pain. HA injections offer various clinical benefits over corticosteroids. HA injections are rapidly adopted among osteoarthritis patients with moderate to severe pain. The surging number of product approvals is expected to augment the segment's growth shortly. On the other hand, corticosteroid injections held second place in the market share. These injections have low annual costs. The platelet-rich plasma injections are expected to witness a promising CAGR in the coming years due to the increasing number of clinical trials. The platelet-rich plasma therapy is done for pain management among osteoarthritis patients.
Based on the joint type, the joint pain injections market is divided into knee and ankle, hip, shoulder and elbow, and others. The knee and ankle dominated the market and accounted for the largest revenue share. The intra-articular injections are highly demanded in knee pain management. The increasing number of people having joint pain in the knee and ankle significantly contributes to the segment's growth. The market players are offering strong product portfolio for the pain treatment associated with knee osteoarthritis. There is high demand for injections for pain management. The product demand is also high for the treatment of knee joints. On the other hand, the hip joint held the second-largest share in the market. This is due to the increasing prevalence of hip osteoarthritis. The rising number of clinical trials drives the segment's growth.
Based on the distribution channel, the joint pain injections market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies dominated the market and accounted for the largest revenue share. This is due to the growing hospitalization rate of patients. The increasing prevalence of orthopedic conditions across the globe significantly contributes to the segment's growth. In line with this, adequate reimbursement policies and the rising sales of intra-articular injections by hospital pharmacies positively influence market growth. The retail pharmacies held second place. This is due to the strong network of retail pharmacy chains. On the other hand, the online distribution channel is expected to witness a promising CAGR in the coming years. This is due to the significant growth of online channels. The changing regulatory policies for prescription drug online sales positively influence the segment's growth. The emergence of new e-pharmacy players in the market catalyzes the segment's growth.
Based on the region, North America dominated the market and accounted for the largest revenue share. It is expected to maintain its dominance in the coming years. This is due to the increasing number of people suffering from joint pain. In line with this, the favorable reimbursement policies for intra-articular injections significantly contribute to the market growth across the region. Furthermore, the market players are focusing on catering to the demand present in the U.S. market. All these factors are expected to positively influence the market growth across the region. In 2018, data was published by the Osteoarthritis Research Society International (ORSI), which stated that around 4.15% of the general population suffered from osteoarthritis (OS) in North America. On the other hand, Europe is the second-largest market. This is due to the increasing number of people suffering from musculoskeletal disorders like arthritis. The launch of novel intra-articular pain injections and a developed healthcare infrastructure positively influence the market growth across the region. Asia Pacific is expected to witness a promising CAGR in the coming years. This is due to the growing prevalence of osteoarthritis. The market players are focusing on introducing viscosupplements. Furthermore, the increasing awareness about join pain injections catalyzes the market growth across the region. Latin America and the Middle East, and Africa regions held the lowest share in the joint pain injections global market. The increasing cases of arthritis propel the market growth across the region. In line with this, the rapid adoption of technologically advanced solutions for pain management significantly contributes to market growth across the region. All these factors are anticipated to drive market growth shortly.
Market Dynamics:
Market Driver: Growing Prevalence of Osteoarthritis and Obesity
The increasing prevalence of Osteoarthritis and Obesity among the general population significantly contributes to market growth across the globe. In line with this, the growing geriatric population and sedentary lifestyle positively influence the market growth. Furthermore, the high prevalence of musculoskeletal disorders catalyzes market growth. Apart from this, the presence of a large patient population suffering from osteoarthritis propels the market growth. Moreover, the growing awareness of early diagnosis & treatment creates a positive outlook for the market. Besides, increasing demand for pain treatment products drives the market growth. The product launches by market players boost the global market.
Market Opportunity: Shift Towards Single Injection Therapy and Plasma Matrix Therapy
The shifting preference towards single injection therapy and plasma Matrix Therapy offers numerous opportunities for market growth. The increasing senior population and rising prevalence of arthritis significantly contribute to the market growth. The growing demand for effective treatment options positively influences the market growth. The market players are developing innovative treatment solutions. The heavy investments in research and development activities to develop novel treatment solutions drive market growth. The market players have introduced single-injection therapy. This therapy is used to treat joint pain.
Market Restraint: High Cost of Injections
The high cost of joint pain injections restricts the market growth. In line with this, the rising prevalence of musculoskeletal disease catalyzes market growth. The surge in demand for effective treatment propels the product demand. However, the high costs of joint injections are expected to hamper the market growth. Moreover, the stringent regulations for product approvals impede the joint pain injections market growth.
Market Challenge: Lack of Reimbursement Policies
The lack of reimbursement policies challenges the joint pain injections market growth, especially in developing and underdeveloped countries. Furthermore, the lack of awareness about joint pain injections in developing countries hampers the market growth. Moreover, the lack of healthcare reimbursement policies impedes the global market.
Key Developments:
Market Key Players:
Market Segmentation
By Injection Type
By Joint Type
By Distribution Channel
By Product Type
Buy this Research Report@ https://www.precedenceresearch.com/checkout/1449
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com| +1 9197 992 333
